清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

医学 溶栓 冲程(发动机) 安慰剂 随机对照试验 临床终点 外科 内科学 麻醉 缺血性中风 缺血 心肌梗塞 机械工程 改良兰金量表 工程类 替代医学 病理
作者
Werner Hacke
出处
期刊:JAMA [American Medical Association]
卷期号:274 (13): 1017-1025 被引量:3454
标识
DOI:10.1001/jama.274.13.1017
摘要

Objective.

—To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke.

Design.

—Randomized, prospective, multicenter, double-blind, placebo-controlled clinical trial.

Setting.

—A total of 75 hospitals in 14 European countries.

Patients.

—A total of 620 patients with acute ischemic hemispheric stroke and moderate to severe neurologic deficit and without major early infarct signs on initial computed tomography (CT).

Intervention.

—Patients were randomized to treatment with 1.1 mg per kilogram of body weight of rt-PA (alteplase) or placebo within 6 hours from the onset of symptoms.

Outcome Measures.

—Primary end points included Barthel Index (BI) and modified Rankin Scale (RS) at 90 days. Secondary end points included combined BI and RS, Scandinavian Stroke Scale (SSS) at 90 days, and 30-day mortality. Tertiary end points included early neurologic recovery (SSS) and duration of in-hospital stay. Safety parameters included mortality and incidence of intracranial or extracranial hemorrhage.

Results.

—The distribution of demographic variables was similar among patients in the rt-PA and placebo treatment arms in both the intention-to-treat (ITT) analysis and the explanatory analysis for the target population (TP). A total of 109 patients (17.4%) were included in the trial despite major protocol violations but excluded from the TP. There was no difference in the primary end points in the ITT analysis, while the TP analysis revealed a significant difference in the RS in favor of rt-PA—treated patients (P<.035). Of the secondary end points, the combined BI and RS showed a difference in favor of rt-PA—treated patients in both analyses (P<.001). Neurologic recovery at 90 days was significantly better for rt-PA—treated patients in the TP (P=.03). The speed of neurologic recovery assessed by the SSS was significantly better up to 7 days in the ITT analysis and up to 30 days for the TP in the rt-PA treatment arm. In-hospital stay was significantly shorter in the rt-PA treatment arm in both analyses. There were no statistically significant differences in the mortality rate at 30 days or in the overall incidence of intracerebral hemorrhages among the rt-PA and placebo treatment arms in either analysis. However, the occurrence of large parenchymal hemorrhages was significantly more frequent in the rt-PA—treated patients.

Conclusions.

—Intravenous thrombolysis in acute ischemic stroke is effective in improving some functional measures and neurologic outcome in a defined subgroup of stroke patients with moderate to severe neurologic deficit and without extended infarct signs on the initial CT scan. However, the identification of this subgroup is difficult and depends on recognition of early major CT signs of early infarction. Therefore, since treating ineligible patients is associated with an unacceptable increase of hemorrhagic complications and death, intravenous thrombolysis cannot currently be recommended for use in an unselected population of acute ischemic stroke patients. (JAMA. 1995;274:1017-1025)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
27秒前
小炮仗完成签到 ,获得积分10
28秒前
老迟到的元霜完成签到,获得积分10
52秒前
叶潭完成签到,获得积分10
1分钟前
JueruiWang1258完成签到,获得积分10
1分钟前
魏白晴完成签到,获得积分10
2分钟前
clock完成签到,获得积分10
3分钟前
1437594843完成签到 ,获得积分10
3分钟前
4分钟前
啦啦发布了新的文献求助10
4分钟前
啦啦完成签到,获得积分10
4分钟前
fhw完成签到 ,获得积分10
5分钟前
5分钟前
zhangzhang发布了新的文献求助10
5分钟前
gwbk完成签到,获得积分10
6分钟前
方白秋完成签到,获得积分10
6分钟前
8分钟前
belssingoo发布了新的文献求助200
8分钟前
万能图书馆应助杜梦婷采纳,获得30
8分钟前
8分钟前
杜梦婷发布了新的文献求助30
9分钟前
9分钟前
结实的半双发布了新的文献求助200
9分钟前
想游泳的鹰完成签到,获得积分10
11分钟前
thangxtz完成签到,获得积分10
11分钟前
隐形曼青应助Ma采纳,获得10
12分钟前
12分钟前
Ma发布了新的文献求助10
12分钟前
andrele应助Ma采纳,获得10
12分钟前
肆肆完成签到,获得积分10
12分钟前
小小果妈完成签到 ,获得积分10
15分钟前
jnrr完成签到 ,获得积分10
15分钟前
杨政远发布了新的文献求助10
16分钟前
SW发布了新的文献求助10
16分钟前
杨政远完成签到,获得积分10
16分钟前
SW完成签到,获得积分10
16分钟前
李小明完成签到,获得积分10
18分钟前
烂漫的蜡烛完成签到 ,获得积分10
18分钟前
紫熊发布了新的文献求助10
19分钟前
19分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Semiconductor Process Reliability in Practice 720
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
The Heath Anthology of American Literature: Early Nineteenth Century 1800 - 1865 Vol. B 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3229738
求助须知:如何正确求助?哪些是违规求助? 2877248
关于积分的说明 8198664
捐赠科研通 2544723
什么是DOI,文献DOI怎么找? 1374636
科研通“疑难数据库(出版商)”最低求助积分说明 647010
邀请新用户注册赠送积分活动 621836